23 Aug 2011
ERJ staff report (DS)
San Diego, California -- Genomatica said it has produced kilo quantities of butadiene made from renewable feedstocks. The company said this achievement confirms the technical viability of Genomatica's bio-based manufacturing process for the dedicated, on-purpose production of butadiene. Global demand is forecasted to be over 20 billion pounds in 2011, or approximately $40 billion based on June 2011 prices.
Genomatica's first process is for commercial production of 1,4-butanediol (BDO), another chemical in the C4 family. The company is currently producing BDO at demonstration scale, with commercial-scale production to begin by the end of 2012, in partnership with Novamont.
Genomatica's second planned commercial process will be for the production of butadiene from renewable feedstocks. The company plans to use its proprietary technology platform to continue to improve process performance and economics.
This is an external link and should open in a new window. If the window does not appear, please check your pop-up blocking software. ERJ is not responsible for the content of external sites.
Press release from Genomatica
Subscribe for unlimited access. A subscription to European Rubber Journal includes:
Already a subscriber? Log in here
